Results 271 to 280 of about 61,117 (342)

Mineralocorticoid receptor antagonism for non-diabetic kidney disease. [PDF]

Nephrol Dial Transplant
Jaisser F, Barrera-Chimal J.
europepmc   +1 more source

Aldosterone-Related Cardiovascular Disease and Benefits of Mineralocorticoid Receptor Antagonists in Clinical Practice. [PDF]

JACC Adv
Alfarano M, Marchionni G, Costantino J, Ballatore F, Verardo R, Miraldi F, Ciciarello FL, Petramala L, Letizia C, Frustaci A, Chimenti C.   +10 more
europepmc   +1 more source

Current practice and perceptions on the use of mineralocorticoid receptor antagonists in the management of heart failure: A cross-sectional study among Indian physicians

Rajeev Garg, Subhash Sonawala, Suvro Banerjee, Aditya Kapoor, Arindam Pande, Amit Sharma, Dharmesh Solanki, P.K Santhoshkumar, Febin Francis, Nitin Zalte, Amarnath Sugumaran, Senthilnathan Mohanasundaram   +11 more
openalex   +1 more source

Comparing the Long-Term Effectiveness of Sodium-Glucose Cotransporter 2 Inhibitors Versus Mineralocorticoid Receptor Antagonists as Add-On Therapies in the Management of Heart Failure: A Systematic Review. [PDF]

Cureus
George V, Pillai MH, Jacob V, Mp R, Vasant A, Adnan H.   +5 more
europepmc   +1 more source

Will mineralocorticoid receptor antagonists give impact on HFpEF pharmacotherapy in addition to SGLT2 inhibitors? [PDF]

Eur Heart J Cardiovasc Pharmacother
Komiyama M, Hasegawa K, Rosano GMC.
europepmc   +1 more source

From Receptor to Repair: The Mechanistic Basis of Mineralocorticoid Receptor Antagonism in Acute Kidney Injury and CKD. [PDF]

Kidney360
Liu R, Lu Y, Juncos LA.
europepmc   +1 more source

Kidney Disease and Mineralocorticoid Receptor

Nihon Naika Gakkai Zasshi, 2009
openaire   +3 more sources

Cardiovascular Outcomes and Hyperkalemia Risk in Patients With Diabetes, Chronic Kidney Disease and Heart Failure: A Real-World Comparison of Non-steroidal versus Steroidal Mineralocorticoid Receptor Antagonists. [PDF]

Cureus
Okunlola AO, Kolawole O, Otabor E, Hassan A, Hamilton M, Alomari L, Lam J, Idowu AB.   +7 more
europepmc   +1 more source